| Name | cycloastragenol |
|---|---|
| Synonyms |
Cyclogalegenin
(3b,6a,16b,24R)-20,24-oxy-9,19-cyclolanostane-3,6,16,25-tetrol Cycloastragenol (Cyclogalagenin (3b,5ξ,6a,9ξ,10ξ,16b,17ξ,24R)-20,24-oxy-9,19-cyclolanostane-3,6,16,25-tetrol Cyclogalgeginin cycloartenol trans-ferulate 78-4 Astramembrangenin CYCLOGALAGENIN; CYCLOGALEGENIN; CYCLOGALEGIGENIN 84-5 Cycloastragenol Plant Extract Powder (3β,6α,9β,16β,20R,24S)-20,24-Epoxy-9,19-cyclolanostane-3,6,16,25-tetrol cas 78-4 Oryzanol A 3-O-ferulylcycloartenol 5-Amino-o-cresol 2-2 Cyclogalegigenin|||Cyclogalagenin|||Astramembrangenin|||Cycloastragenol (2,3R,4S,5aS,5bS,7S,7,9S,11,12aS)-3-((2S,5R)-5-(2-Hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyltetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthrene-4,7,9-triol (3beta,6alpha,16beta,24R)-20,24-oxy-9,19-cyclolanostane-3,6,16,25-tetrol Cycloastragenol Powder from Astragulus Extract Cycloastragenol cas 78-4 Cyclogalagenin cycloartenyl ferulate Ring astragalus alcohol Astragalus Extract HPLC Test Cycloastragenol Powder84-5 9,19-Cyclolanostane-3,6,16,25-tetrol, 20,24-oxy-, (3β,6α,16β,24R) Cyclogalegenin, 10 mM in DMSO Cycloastrageno Cyclogalegigenin Cycloartenol ferulic acid ester CYCLOGALEGENIN |
| Description | Cycloastragenol, a natural tetracyclic triterpenoid, was first identified when screening Astragalus membranaceus extracts for active ingredients with antiaging properties. IC50 value:Target:In vitro: In the study of Cycloastragenolon the treatment of degenerative diseases, the result showed that first-pass intestinal metabolism of cycloastragenol might occur upon passage through the intestinal epithelium. Cycloastragenol underwent extensive metabolism in rat and human liver microsomes with only 17.4% and 8.2%, respectively, of the starting amount of Cycloastragenol remaining after 30 min of incubation [1]. The present study demonstrates that cycloastragenol stimulates telomerase activity and cell proliferation in human neonatal keratinocytes. In particular, cycloastragenol promotes scratch wound closure of human neonatal keratinocyte monolayers in vitro [3]. In vivo: Rats were treated with Cycloastragenol (40 mg·kg- 1·d- 1) for 7 days to induce hepatic microsomal enzyme. The result showed that compared with the control, cycloastragenol obviously activated CYP2E1, and remarkably inhibited CYP3A4 [2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 617.2±55.0 °C at 760 mmHg |
| Molecular Formula | C30H50O5 |
| Molecular Weight | 490.715 |
| Flash Point | 327.1±31.5 °C |
| Exact Mass | 490.365814 |
| PSA | 90.15000 |
| LogP | 3.82 |
| Vapour Pressure | 0.0±4.0 mmHg at 25°C |
| Index of Refraction | 1.582 |
| Storage condition | -20°C |
| HS Code | 2942000000 |
|---|
| Precursor 9 | |
|---|---|
| DownStream 0 | |
| HS Code | 2942000000 |
|---|